Related Experiment Video
Updated: Jul 19, 2026
04:40
Venous Thrombosis Assay in a Mouse Model of Cancer
Published on: January 5, 2024
Cancer and venous thromboembolism
Andrea Piccioli1, Anna Falanga, Ugo Baccaglini
1Department of Medical and Surgical Sciences, University of Padua, Padua, Italy. andreapiccioli@libero.it
Seminars in Thrombosis and Hemostasis
|October 7, 2006
Summary
Cancer patients have a higher risk of venous thromboembolism (VTE). Research identifies VTE risk factors and treatments, with anticoagulants showing potential benefits for cancer prognosis and survival.
Area of Science:
- Oncology and Hematology
- Clinical Medicine
Background:
- A significant two-way clinical correlation exists between cancer and venous thromboembolism (VTE).
- Cancer patients face an elevated risk of VTE compared to non-cancer patients.
- Idiopathic VTE can sometimes indicate an underlying, undiagnosed cancer.
Purpose of the Study:
- To review the established relationship between cancer and VTE.
- To summarize research on VTE risk factors in cancer patients.
- To assess optimal thromboprophylaxis, treatment, and secondary prophylaxis strategies.
- To explore the potential of anticoagulant drugs in cancer treatment and patient survival.
Main Methods:
- Literature review and synthesis of existing research findings.
- Analysis of identified VTE risk factors in oncological patients.
- Evaluation of current thromboprophylaxis and treatment guidelines.
- Assessment of emerging evidence on anticoagulant therapy in cancer.
Main Results:
- Established correlation between cancer and increased VTE risk.
- Identification of key risk factors for VTE in cancer patients.
- Evidence suggesting potential prognostic and survival benefits of anticoagulants in cancer treatment.
Conclusions:
- The link between cancer and VTE is well-documented, necessitating proactive management.
- Research has advanced the understanding and treatment of VTE in cancer.
- Anticoagulant therapy presents a promising avenue for improving cancer outcomes.
Related Concept Videos
01:30Venous Thrombosis I: Introduction
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
01:30Venous Thrombosis IV: Nursing Management
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
01:19Pulmonary Embolism I: Introduction
A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...
01:29Pulmonary Embolism I: Introduction
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...